New-home construction surged in November to a six-month high. This brisk pace of homebuilding bodes well for the equity rally. Read More

New-home construction surged in November to a six-month high. This brisk pace of homebuilding bodes well for the equity rally. Read More

We review recent market action and explain why the rally has momentum. We also provide a profitable way to beat Wall Street at its own game. Read More

We review recent market action and explain why the rally has momentum. We also provide a profitable way to beat Wall Street at its own game. Read More

The pessimists said beating inflation without a recession was impossible. Welcome to this year’s Christmas miracle: an economic soft landing. Read More

The pessimists said beating inflation without a recession was impossible. Welcome to this year’s Christmas miracle: an economic soft landing. Read More

In this question-and-answer session, the editorial director of Investing Daily provides his outlook for the markets in the new year. Read More

In this question-and-answer session, the editorial director of Investing Daily provides his outlook for the markets in the new year. Read More

Stocks are in an uptrend, but winners and losers are emerging, based on a particular industry's sensitivity to interest rate fluctuations. Read More

Stocks are in an uptrend, but winners and losers are emerging, based on a particular industry's sensitivity to interest rate fluctuations. Read More

Favorable inflation data this week gave the Fed the elbow room to once again pause, providing further upward momentum for the stock market. Read More

Favorable inflation data this week gave the Fed the elbow room to once again pause, providing further upward momentum for the stock market. Read More

The research shows that the pain-relieving effects of these psychedelic substances intensify with repeated treatment, in contrast to opioids. Read More

The research shows that the pain-relieving effects of these psychedelic substances intensify with repeated treatment, in contrast to opioids. Read More

Projected corporate earnings growth remains strong for the rest of 2023 and into 2024, an indication that the stock market rally has legs. Read More

Projected corporate earnings growth remains strong for the rest of 2023 and into 2024, an indication that the stock market rally has legs. Read More

How do you know when it’s time to sell? There are no perfect answers, but here are a few tips that will help you know when it's time... Read More

How do you know when it’s time to sell? There are no perfect answers, but here are a few tips that will help you know when it's time... Read More

Public confidence in the economy is returning. In the final weeks of 2023, stocks are positioned to close near their yearly highs. Read More

Public confidence in the economy is returning. In the final weeks of 2023, stocks are positioned to close near their yearly highs. Read More